Abstract
Stereotactic ablative radiotherapy for the primary site in a patient with nonmetastatic castration-resistant prostate cancer
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have